Cookie Settings
We use cookies to provide the best possible website experience for you. This includes cookies that are technically required to ensure a proper functioning of the website, as well as cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for displaying personalized content. You are free to choose the categories you would like to permit. Please note that depending on your settings, the full functionality of the website may no longer be available. Further information can be found in our Privacy Statement and Cookie Statement.
Separation of CD8 + cells from PBMCs using CD8 MicroBeads, an LS Column, and a MidiMACS™ Separator. |
PBMCs before separation | CD8 - cells |
CD8 MicroBeads, humanFigure 1Separation of CD8 + cells from PBMCs using CD8 MicroBeads, an LS Column, and a MidiMACS™ Separator. | CD8 MicroBeads, humanFigure 1Separation of CD8 + cells from PBMCs using CD8 MicroBeads, an LS Column, and a MidiMACS™ Separator. |
CD8 + cells | |
CD8 MicroBeads, humanFigure 1Separation of CD8 + cells from PBMCs using CD8 MicroBeads, an LS Column, and a MidiMACS™ Separator. |
Our lab routinely works with purified immune cell subsets from human peripheral blood mononuclear cells (PBMC). In order to obtain highly pure CD8+ T cells, as well as other immune cell types, we routinely employ magnetic separation with Miltenyi products for positive selection because of their ease of use and minimal optimization. We require highly pure CD8+ T cells due to the nature of our downstream analysis, and this product helps us achieve this goal.
The general aim of my research is to investigate the role of TCRs in the function of CTLs. For that we isolated TCR genes from T cell clones isolated from HIV patients and cloned them into lentiviral vectors to use for transduction of primary CD8 T cells isolated from naive patients. These transduced cells are then used for further study to evaluate their ability to recognize their cognate peptide and their killing capacity of infected cells. We selected this product because we had access to the AutoMACSpro, an automated machine used for cell separation compatible with these beads.
We are interested in enhancing the killing capacity of HIV-specific CD8 T cells by reengineering TCRs expressed by these cells. We use purified CD8 T cells from donors with known HLA types, to transduce them with the desired lentiviral construct and test their in vitro activity against HIV infected cells.
Great reagent to use for positive selection of CD8+ cells
Separation of CD8 + cells from PBMCs using CD8 MicroBeads, an LS Column, and a MidiMACS™ Separator. |
PBMCs before separation | CD8 - cells |
CD8 MicroBeads, humanFigure 1Separation of CD8 + cells from PBMCs using CD8 MicroBeads, an LS Column, and a MidiMACS™ Separator. | CD8 MicroBeads, humanFigure 1Separation of CD8 + cells from PBMCs using CD8 MicroBeads, an LS Column, and a MidiMACS™ Separator. |
CD8 + cells | |
CD8 MicroBeads, humanFigure 1Separation of CD8 + cells from PBMCs using CD8 MicroBeads, an LS Column, and a MidiMACS™ Separator. |
Our lab routinely works with purified immune cell subsets from human peripheral blood mononuclear cells (PBMC). In order to obtain highly pure CD8+ T cells, as well as other immune cell types, we routinely employ magnetic separation with Miltenyi products for positive selection because of their ease of use and minimal optimization. We require highly pure CD8+ T cells due to the nature of our downstream analysis, and this product helps us achieve this goal.
The general aim of my research is to investigate the role of TCRs in the function of CTLs. For that we isolated TCR genes from T cell clones isolated from HIV patients and cloned them into lentiviral vectors to use for transduction of primary CD8 T cells isolated from naive patients. These transduced cells are then used for further study to evaluate their ability to recognize their cognate peptide and their killing capacity of infected cells. We selected this product because we had access to the AutoMACSpro, an automated machine used for cell separation compatible with these beads.
We are interested in enhancing the killing capacity of HIV-specific CD8 T cells by reengineering TCRs expressed by these cells. We use purified CD8 T cells from donors with known HLA types, to transduce them with the desired lentiviral construct and test their in vitro activity against HIV infected cells.
Great reagent to use for positive selection of CD8+ cells
Seems like you are coming from USA!
Do you want to visit our website in your country?
Copyright © 2023 Miltenyi Biotec and/or its affiliates. All rights reserved.